CG Oncology, Inc. Common stock (CGON) Free Cash Flow
CG Oncology, Inc. Common stock (CGON) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2024-12-31 | -$78.95M |
| 2025-12-31 | -$132.43M |
How CGON compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| VNDA | Vanda Pharmaceuticals Inc. | -$110.44M |
| RGNX | REGENXBIO Inc. | -$126.38M |
| VYGR | Voyager Therapeutics Inc. | -$135.06M |
| VSTM | Verastem Inc. | -$147.13M |
| CELC | Celcuity Inc. | -$153.53M |
These are five companies in the same sector as CGON with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get CG Oncology, Inc. Common stock Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("CGON", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CGON | $79.01 | +0.75% | 0.33M |
| 3 | ||||
| 4 | ||||
| 5 |